Syndax Pharmaceuticals (SNDX) EBT Margin (QoQ) (2015 - 2026)
Syndax Pharmaceuticals (SNDX) EBT Margin (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 518.00 |
| Mar 31, 2026 | -1,592.00 |
| Dec 31, 2025 | 8,229.00 |
| Sep 30, 2025 | 6,776.00 |
| Jun 30, 2025 | 22,243.00 |
| Mar 31, 2025 | 80,372.00 |
| Dec 31, 2024 | -55,244.00 |
| Sep 30, 2024 | 147,228.00 |
| Dec 31, 2021 | 24,177.00 |
| Sep 30, 2021 | 589,160.00 |
| Jun 30, 2021 | 126,992.00 |
| Mar 31, 2021 | -196,244.00 |
| Dec 31, 2020 | -642.00 |
| Sep 30, 2020 | -82,639.00 |
| Jun 30, 2020 | -44,274.00 |
| Mar 31, 2020 | -71,471.00 |
| Dec 31, 2019 | 41,418.00 |
| Sep 30, 2019 | 60,290.00 |
| Jun 30, 2019 | -45,620.00 |
| Mar 31, 2019 | 156,964.00 |